quality replica watches
4.75(4)

#HC-02-38 Measuring and Valuing Health

About Course

The University of Sheffield

Description

Explore how and why we decide what drugs and treatments should be funded

Healthcare systems around the world are increasingly under pressure to fund new drugs, treatments and other healthcare interventions.

On this course, you’ll learn how health outcome measuring can help us to make more informed decisions about where to spend our limited healthcare budgets.

You’ll find out how patient-reported outcome measures (PROMs) and quality-adjusted life years (QALYs) are developed and calculated, and learn how they can be used to compare treatment benefits in practice.

What topics will you cover?

The course focuses on two different types of measures, asking how they’re developed and calculated, and how they’re used by decision makers in practice:

  • Patient Reported Outcome Measures (PROMs): which are measures completed by the patients themselves, about their health, symptoms, functioning, well-being or satisfaction with treatment.
  • Quality Adjusted Life Years (QALYs): which compare the benefits of different treatment options, based on the quality and quantity of life they yield.

Who will you learn with?

Clara Mukuria

I am a Health Economist at ScHARR in the University of Sheffield. My research interests are in measuring and valuing health related quality of life and well-being.

 

 

Katherine Stevens

I am a Health Economist working in ScHARR at The University of Sheffield. My research interest is measuring and valuing children’s health related quality of life.

 

 

Who developed the course?

The University of Sheffield

The University of Sheffield is one of the world’s top 100 universities with a reputation for teaching and research excellence.

What Will I Learn?

  • Discuss what health means and how to measure its impact on quality of life.
  • Evaluate how to develop and use patient reported outcome measures including their limitations in decision-making.
  • Calculate QALYs in simple examples to arrive at values which can be used to compare treatment benefits.
  • Perform a time trade off to develop an understanding of how this method can be used to value health states and generate preference weights.
  • Debate who should value our health. Should it be patients, health professionals or the general public and should this be different for children’s health?
  • Compare where QALYs are used in healthcare decision-making worldwide and discuss the merits of this method compared to those used where you live.

Topics for this course

11 Lessons13h

The challenge of measuring health?

In this activity we look at the broad definition of health and the challenges involved in measuring it.
What does health mean to you?
How can we measure health?
Types of measures of health
The challenge of creating a generic measure of HRQoL00:03:22

Patient Reported Outcome Measures?

We introduce you to PROMs; what they are, how they are developed and how they are tested and validated. We then take a look at generic and condition specific PROMs, finding out the advantages and disadvantages of each.

Student Feedback

4.8

Total 4 Ratings

5
3 ratings
4
1 rating
3
0 rating
2
0 rating
1
0 rating

The instructor and the information are engaging and excellent! I'm so excited to be on this new journey.

This course was very informative. The layout was amazing and Louis Anne Maurice is a great instructor.

A well-structured course enabling me to deliver a well-structured coaching program to my own clients.

This course melds nicely with my coaching tools and my own holistic lifestyle.

$29

Material Includes

  • Official Certificate

Target Audience

  • This course is designed for anyone interested in how and why choices about drugs and treatments have been made.
  • It is ideal learning for anyone considering a career in healthcare, local decision-making or academia.
  • If you wish to take your learning further, the University of Sheffield’s other Masters degrees and short courses address areas such as health economics, public health and international healthcare technology assessment.